|
The purpose of this
course is to assist healthcare workers in avoiding needlestick injuries
and to provide an update on current CDC recommendations of treatment
after a needlestick.
After completing the
course the learner will be able to:
|
1. |
identify the way that
needlestick injuries can
best be reduced, |
|
|
|
|
2. |
recognize the risk of
occupational transmission of
HIV, HBV and HCV, |
|
|
|
|
3. |
discuss the limited value of
pre-exposure vaccination or
post-exposure prophylaxis, |
|
|
|
|
4. |
identify devices and
activities most commonly
associated with needlestick
injuries, and |
|
|
|
|
5. |
identify the desirable
characteristics of safety
devices. |
The CDC estimates that 384,325
percutaneous injuries occur each
year in U.S. hospitals. According TO
EPINet (Exposure Prevention
Information Network) data for 2001.
Nurses sustained the largest
proportion (44%) of sharps injuries
of all healthcare professionals, but
laboratory staff, physicians,
housekeepers, and other healthcare
workers are also injured (Perry,
Jagger & Parker, 2003). Some of
these injuries expose workers to
bloodborne pathogens that can cause
infection. The most important of
these pathogens are HBV, HCV, and
HIV. Infections with each of these
pathogens are potentially life
threatening—and preventable.
Employers of healthcare workers
should implement the use of improved
engineering controls to reduce
needlestick injuries:
|
Eliminate the use of needles
where safe and effective
alternatives are available. |
|
|
|
|
Implement the use of devices
with safety features and
evaluate their use to
determine which are most
effective and acceptable. |
Since 1993 the use of
safety-engineered sharps devices has
increased while the use of
conventional sharps devices has
decreased. Percutaneous injury rates
decreased dramatically (Perry,
Jagger & Parker, 2003). Needlestick
injuries can best be reduced when
the use of improved engineering
controls is incorporated into a
comprehensive program involving
workers. Employers should implement
the following program elements
(NIOSH, 1999):
|
Analyze needlestick and
other sharps-related
injuries in your workplace
to identify hazards and
injury trends. |
|
|
|
|
Set priorities and
strategies for prevention by
examining local and national
information about risk
factors for needlestick
injuries and successful
intervention efforts. |
|
|
|
|
Ensure that healthcare
workers are properly trained
in the safe use and disposal
of needles. |
|
|
|
|
Modify work practices that
pose a needlestick injury
hazard to make them safer. |
|
|
|
|
Promote safety awareness in
the work environment. |
|
|
|
|
Establish procedures for and
encourage the reporting and
timely followup of all
needlestick and other
sharps-related injuries. |
|
|
|
|
Evaluate the effectiveness
of prevention efforts and
provide feedback on
performance. |
Healthcare workers should take the
following steps to protect
themselves and their fellow workers
from needlestick injuries (NIOSH,
1999):
|
Avoid the use of needles
where safe and effective
alternatives are available. |
|
|
|
|
Help your employer select
and evaluate devices with
safety features. |
|
|
|
|
Use devices with safety
features provided by your
employer. |
|
|
|
|
Avoid recapping needles. |
|
|
|
|
Plan for safe handling and
disposal before beginning
any procedure using needles. |
|
|
|
|
Dispose of used needles
promptly in appropriate
sharps disposal containers. |
|
|
|
|
Report all needlestick and
other sharps-related
injuries promptly to ensure
that you receive appropriate
followup care. |
|
|
|
|
Tell your employer about
hazards from needles that
you observe in your work
environment. |
|
|
|
|
Participate in bloodborne
pathogen training and follow
recommended infection
prevention practices,
including hepatitis B
vaccination. |
Percutaneous needlestick injuries
are caused by needles such as
hypodermic needles, blood collection
needles, intravenous (IV) stylets,
and needles used to connect parts of
IV delivery systems. These injuries
may cause a number of serious and
potentially fatal infections with
bloodborne pathogens such as
hepatitis B virus (HBV), hepatitis C
virus (HCV), or human
immunodeficiency virus (HIV)—the
virus that causes acquired
immunodeficiency syndrome (AIDS).
These injuries can be avoided by
eliminating the unnecessary use of
needles, using devices with safety
features, and promoting education
and safe work practices for handling
needles and related systems. These
measures should be part of a
comprehensive program to prevent the
transmission of bloodborne
pathogens.
The emotional impact of a
needlestick injury can be severe and
long lasting, even when a serious
infection is not transmitted. This
impact is particularly severe when
the injury involves exposure to HIV.
In one study of 20 healthcare
workers with an HIV exposure, 11
reported acute severe distress, 7
had persistent moderate distress,
and 6 quit their jobs as a result of
the exposure (NIOSH, 1999). Other
stress reactions requiring
counseling have also been reported.
Not knowing the infection status of
the source patient can accentuate
the healthcare worker’s stress. In
addition to the exposed healthcare
worker, colleagues and family
members may suffer emotionally.
HIV
Between 1985 and June 1999,
cumulative totals of 55
"documented"† cases and 136 possible
cases of occupational HIV
transmission to U.S. healthcare
workers were reported to the Centers
for Disease Control and Prevention (NIOSH,
1999). Most involved nurses and
laboratory technicians. Percutaneous
injury (e.g., needlestick) was
associated with 49 (89%) of the
documented transmissions. Of these,
44 involved hollow-bore needles,
most of which were used for blood
collection or insertion of an IV
catheter.
HIV infection is a complex disease
that can be associated with many
symptoms. The virus attacks part of
the body’s immune system, eventually
leading to severe infections and
other complications—a condition
known as AIDS. Despite current
therapies that delay the progression
of HIV disease, most healthcare
workers who become infected with HIV
are likely to eventually develop
AIDS and die.
HBV
In 1995, an estimated 800 healthcare
workers became infected with HBV.
This figure represented a 95%
decline from the 17,000 new
infections estimated in 1983. The
decline was largely due to the
widespread immunization of
healthcare workers with the
hepatitis B vaccine and the use of
universal precautions and other
measures required by the
Occupational Safety and Health
Administration (OSHA) bloodborne
pathogens standard (NIOSH, 1999).
About one-third to one-half of
persons with acute HBV infection
develop symptoms of hepatitis such
as jaundice, fever, nausea, and
abdominal pain. Most acute
infections resolve, but 5% to 10% of
patients develop chronic infection
with HBV that carries an estimated
20% lifetime risk of dying from
cirrhosis and 6% risk of dying from
liver cancer (NIOSH. 1999).
HCV
Hepatitis C virus infection is the
most common chronic bloodborne
infection in the United States,
affecting approximately 4 million
people. Although the prevalence of
HCV infection among healthcare
workers is similar to that in the
general population (1% to 2%),
healthcare workers clearly have an
increased occupational risk for HCV
infection (NIOSH. 1999). The number
of healthcare workers who have
acquired HCV occupationally is not
known. However, of the total acute
HCV infections that have occurred
annually (ranging from 100,000 in
1991 to 36,000 in 1996), 2% to 4%
have been in healthcare workers
exposed to blood in the workplace
(NIOSH. 1999).
HCV infection often occurs with no
symptoms or only mild symptoms. But
unlike HBV, chronic infection
develops in 75% to 85% of patients,
with active liver disease developing
in 70%. Of the patients with active
liver disease, 10% to 20% develop
cirrhosis, and 1% to 5% develop
liver cancer (NIOSH. 1999).
After a needlestick exposure to an
infected patient, a healthcare
worker's risk of infection depends
on the pathogen involved, the immune
status of the worker, the severity
of the needlestick injury, and the
availability and use of appropriate
post-exposure prophylaxis.
HIV
The Centers for Disease Control and
Prevention's (CDC) published
guidelines contend that the risk of
healthcare personnel obtaining HIV
infection from a percutaneous stick
is .3% (DesRoches, 2003). One study
of healthcare workers who had
percutaneous exposures to HIV found
that the risk of HIV transmission
was increased when the worker was
exposed to a larger quantity of
blood from the patient, as indicated
by (1) a visibly bloody device, (2)
a procedure that involved placing a
needle in a patient's vein or
artery, or (3) a deep injury (NIOSH.
1999).
Post-exposure prophylaxis for HIV is
recommended for healthcare workers
occupationally exposed to HIV under
certain circumstances. Early
intervention with post-exposure
prophylaxis (PEP) medication for 4
weeks post-exposure may prevent HIV
infection by blocking spread of the
virus to target cells or into the
lymph system. Evidence weighs
heavily on introducing PEP within 24
to 48 hours after an exposure to a
patient who is an HIV positive
source, a patient with HIV risk
factors, or an exposure where the
source patient is unknown but
contact with patients who are HIV
positive is high (DesRoches, 2003).
Limited data suggest that such
prophylaxis may considerably reduce
the chance of becoming infected with
HIV. However, the drugs used for HIV
post-exposure prophylaxis have many
adverse side effects. Currently no
vaccine exists to prevent HIV
infection, and no treatment exists
to cure it (NIOSH. 1999).
HBV
The rate of HBV transmission to
susceptible healthcare workers
ranges from 6% to 30% after a single
needlestick exposure to an
HBV-infected patient (NIOSH. 1999).
However, such exposures are a risk
only for healthcare workers who are
not immune to HBV. Healthcare
workers who have antibodies to HBV
either from pre-exposure vaccination
or prior infection are not at risk.
In addition, if a susceptible worker
is exposed to HBV, post-exposure
prophylaxis with hepatitis B immune
globulin and initiation of hepatitis
B vaccine is more than 90% effective
in preventing HBV infection.
HCV
Recent research had identified
significantly lower transmission
rates of hepatitis C virus (HCV) in
healthcare workers injured by
HCV-contaminated needles. Studies of
healthcare workers exposed to HCV
through a needlestick or other
percutaneous injury have found that
the incidence of anti-HCV
seroconversion (indicating
infection) 0.5%. The Centers for
Disease Control and Prevention (CDC)
recommend testing for HCV antibodies
and alanine aminotransferase levels
initially and at 4 to 6 months after
exposure, or-for earlier
diagnosis-for HCV RNA at 4 to 6
weeks (Perry, Jagger & Parker,
2003). Currently no vaccine exists
to prevent HCV infection, and
neither immunoglobulin nor antiviral
therapy is recommended as
post-exposure prophylaxis (NIOSH.
1999). However, recommendations for
treatment of early infections are
rapidly evolving. Healthcare workers
with known exposure should be
monitored for seroconversion and
referred for medical follow-up if
seroconversion occurs.
Although exposure to HBV poses a
high risk for infection,
administration of pre-exposure
vaccination or post-exposure
prophylaxis to workers can
dramatically reduce this risk. Such
is not the case with HCV and HIV.
Preventing the needlestick injury is
the best approach to preventing
these diseases in healthcare
workers, and it is an important part
of any bloodborne pathogen
prevention program in the workplace.
Organizational factors appear
important in healthcare workers'
risk of injury. Working in hospitals
using professional nurse practice
models is associated with a
several-fold reduction in the risk
of injury (odds ratio, 0.18 to 0.37)
among nurses. Further, nurse
staffing ratios and the hospital
safety climate have been shown to
relate to the risk of percutaneous
injury. Even when "safer" sharps
devices are made available and used,
they are often not adequately
activated (Boebbeling, 2003)
Distraction, anger, and rushing were
associated with the largest increase
in risk of sharps-related injuries
in one study. A trend toward
increased risk of injury was seen
when workers were fatigued, working
on understaffed teams, dealing with
an uncooperative patients, and among
surgeons working in a noisy
operating room (Anonymous, 2003).
Devices Associated with Needlestick
Injuries
Healthcare workers use many types of
needles and other sharp devices to
provide patient care. However, data
from hospitals participating in the
CDC National Surveillance System for
Hospital Healthcare Workers (NaSH)
and from hospitals included in the
EPINet research database show that
only a few needles and other sharp
devices are associated with the
majority of injuries (NIOSH. 1999).
Of nearly 5,000 percutaneous
injuries reported by hospitals
participating in NaSH between June
1995 and July 1999, 62% were
associated with hollow-bore
needles—primarily hypodermic needles
attached to disposable syringes
(29%) and winged-steel
(butterfly-type) needles (13%).
Figure 1 shows the extent to which
these and other sharp devices
contributed to the burden of
percutaneous injuries in NaSH
hospitals. Data from hospitals
participating in EPINet show a
similar distribution of injuries by
device type (NIOSH. 1999).
Activities Associated with
Needlestick Injuries
Whenever a needle or other sharp
device is exposed, injuries can
occur. Data from NaSH show that
approximately 38% of percutaneous
injuries occur during use and 42%
occur after use and before disposal.
Causes of percutaneous injuries with
hollow-bore needles are shown in
Figure 2.
The circumstances leading to a
needlestick injury depend partly on
the type and design of the device
used. For example, needle devices
that must be taken apart or
manipulated after use (e.g.,
prefilled cartridge syringes and
phlebotomy needle/vacuum tube
assemblies) are an obvious hazard
and have been associated with
increased injury rates (NIOSH.
1999). In addition, needles attached
to a length of flexible tubing
(e.g., winged-steel needles and
needles attached to IV tubing) are
sometimes difficult to place in
sharps containers and thus present
another injury hazard. Injuries
involving needles attached to IV
tubing may occur when a healthcare
worker inserts or withdraws a needle
from an IV port or tries to
temporarily remove the needlestick
hazard by inserting the needle into
a drip chamber, IV port or bag, or
even bedding.
In addition to risks related to
device characteristics, needlestick
injuries have been related to
certain work practices such as
|
recapping, |
|
|
|
|
transferring a body fluid
between containers, and |
|
|
|
|
failing to properly dispose
of used needles in
puncture-resistant sharps
containers. |
Past studies of needlestick injuries
have shown that 10% to 25% occurred
when recapping a used needle (NIOSH.
1999). Although recapping by hand
has been discouraged for some time
and is prohibited under the OSHA
bloodborne pathogens standard [29
CFR 1910.1030] unless no alternative
exists, 5% of needlestick injuries
in NaSH hospitals are still related
to this practice (Figure 2). Injury
may occur when a healthcare worker
attempts to transfer blood or other
body fluids from a syringe to a
specimen container (such as a vacuum
tube) and misses the target. Also,
if used needles or other sharps are
left in the work area or are
discarded in a sharps container that
is not puncture resistant, a
needlestick injury may result.
OSHA
The current Federal standard for
addressing needlestick injuries
among healthcare workers is the OSHA
bloodborne pathogens standard [29
CFR 1910.1030; 56 Federal Register
64004 (1991)], which has been in
effect since 1992. The standard
applies to all occupational
exposures to blood or other
potentially infectious materials.
Notable elements of this standard
require the following (NIOSH. 1999):
|
A written exposure control
plan designed to eliminate
or minimize worker exposure
to bloodborne pathogens |
|
|
|
 |
Compliance with universal
precautions (an infection
control principle that
treats all human blood and
other potentially infectious
materials as infectious) |
|
|
|
 |
Engineering controls and
work practices to eliminate
or minimize worker exposure |
|
|
|
 |
Personal protective
equipment (if engineering
controls and work practices
do not eliminate
occupational exposures) |
|
|
|
 |
Prohibition of bending,
recapping, or removing
contaminated needles and
other sharps unless such an
act is required by a
specific procedure or has no
feasible alternative |
|
|
|
 |
Prohibition of shearing or
breaking contaminated
needles (OSHA defines
contaminated as the presence
or the reasonably
anticipated presence of
blood or other potentially
infectious materials on an
item or surface) |
|
|
|
 |
Free hepatitis B
vaccinations offered to
workers with occupational
exposure to bloodborne
pathogens |
|
|
|
 |
Worker training in
appropriate engineering
controls and work practices |
|
|
|
 |
Post-exposure evaluation and
followup, including
post-exposure prophylaxis
when appropriate |
OSHA also intends to act to reduce
the number of injuries that
healthcare workers receive from
needles and other sharp medical
objects. First, the agency has
revised the compliance directive
(guidance to be used in the field)
accompanying its 1992 bloodborne
pathogens standard [29 CFR
1910.1030] to reflect newer and
safer technologies now available and
to increase the employer's
responsibility to evaluate and use
effective, safer technologies (NIOSH.
1999). Second, the agency has
proposed a requirement in the
revised recordkeeping rule that all
injuries resulting from contaminated
needles and sharps be recorded on
OSHA logs used by employers to
record injuries and illnesses.
Finally, OSHA will take steps to
amend its bloodborne pathogens
standard by placing needlestick and
sharps injuries on its regulatory
agenda.
FDA
Under the regulations of the Food
and Drug Administration (FDA)
application clearance process, the
manufacturers of medical devices
(including needles used in patient
care) must meet requirements for
appropriate registration and for
listing, labeling, and good
manufacturing practices for design
and production. The process for
receiving clearance or approval to
market a device requires device
manufacturers to (1) demonstrate
that a new device is substantially
equivalent to a legally marketed
device or (2) document the safety
and effectiveness of the new device
for patient care through a more
involved premarket approval process.
FDA has also released two advisories
pertaining to sharps and the risk of
bloodborne pathogen transmission in
the healthcare setting (NIOSH.
1999).
The following case reports briefly
describe the experiences of five
healthcare workers who developed
serious infections after
occupational exposures to bloodborne
pathogens (NIOSH. 1999). Their cases
illustrate a number of the
preventable
hazardous conditions and practices
that can lead to needlestick
injuries.
Case 1
A hospitalized patient with AIDS
became agitated and tried to remove
the intravenous (IV) catheters in
his arm. Several hospital staff
members struggled to restrain the
patient. During the struggle, an IV
infusion line was pulled, exposing
the connector needle that was
inserted into the access port of the
IV catheter. A nurse at the scene
recovered the connector needle at
the end of the IV line and was
attempting to reinsert it when the
patient kicked her arm, pushing the
needle into the hand of a second
nurse. The nurse who sustained the
needlestick injury tested negative
for HIV that day, but she tested HIV
positive several months later.
Case 2
A physician was drawing blood from a
patient in an examination room of an
HIV clinic. Because the room had no
sharps disposal container, she
recapped the needle using the
one-handed technique. While the
physician was sorting waste
materials from lab materials, the
cap fell off the phlebotomy needle,
which subsequently penetrated her
right index finger. The physician's
baseline HIV test was negative. She
began post-exposure prophylaxis with
zidovudine but discontinued it after
10 days because of adverse side
effects. Approximately 2 weeks after
the needlestick, the physician
developed flu-like symptoms
consistent with HIV infection. She
was found to be seropositive for HIV
when tested 3 months after the
needlestick exposure.
Case 3
After performing phlebotomy on a
patient with AIDS, a healthcare
worker sustained a deep needlestick
injury with the used phlebotomy
needle. Blood from the collection
tube also spilled into the space
between the wrist and cuff of the
healthcare worker's gloves,
contaminating her chapped hands. The
healthcare worker removed the gloves
and washed her hands immediately.
She had a negative baseline HIV test
and refused zidovudine prophylaxis.
Because her patient was not known to
have HCV infection and did not have
clinical evidence of liver disease,
the healthcare worker did not
receive baseline testing for
exposure to HCV. Eight months after
the incident, the healthcare worker
was hospitalized with acute
hepatitis. She was found to be
seropositive for HIV nine months
after the incident. Sixteen months
after the incident, she tested
positive for anti-HCV antibodies and
was diagnosed with chronic HCV
infection. Her clinical condition
continued to deteriorate, and she
died 28 months after the needlestick
injury.
Case 4
During bronchoscopy to determine the
cause of shortness of breath in a
patient infected with HBV, a
healthcare worker sustained a
percutaneous injury with a 25-gauge
needle while extracting tissue from
biopsy forceps. The worker did not
receive post-exposure prophylaxis
with hepatitis B immune globulin or
hepatitis B vaccine. Approximately
15 weeks after the needlestick
injury, the worker noted fatigue,
malaise, and jaundice. Later, he was
found to have abnormal liver enzymes
and a positive test for hepatitis B
surface antigen, consistent with
acute hepatitis B infection. The
patient who underwent bronchoscopy
was diagnosed with Pneumocystis
carinii pneumonia and died 8 months
later after he was diagnosed with
disseminated Kaposi's sarcoma and
overwhelming opportunistic
infection. The injured worker had an
uncomplicated medical course, and
his liver enzymes and his health
eventually returned to normal. He
later tested negative for hepatitis
B surface antigen and positive for
hepatitis B surface antibody,
indicating recovery from his HBV
infection. On followup 15 months
after the needlestick injury, the
worker also tested HIV negative;
serum from the deceased patient was
not available for antibody testing.
Case 5
In 1972, a nurse sustained a
needlestick injury to her finger
while removing a hypodermic needle
from a patient's arm. At the time of
the injury, the source patient had
apparent acute non-A, non-B
hepatitis. The nurse developed
hepatitis 6 weeks after the
needlestick injury. Her liver
enzymes remained elevated for nearly
a year. Later examination of serum
samples from the nurse and the
source patient showed that both
persons were infected with HCV. The
initial serum sample from the nurse
in 1972 was negative for anti-HCV
antibody, but the sample obtained 6
weeks after the needlestick injury
was seropositive. Although the nurse
was clinically well at the time of
the report, she remained
seropositive for HCV.
Comprehensive Programs to Prevent
Needlestick Injuries
Safety and health issues can best be
addressed in the setting of a
comprehensive prevention program
that considers all aspects of the
work environment and that has
employee involvement as well as
management commitment. Implementing
the use of improved engineering
controls is one component of such a
comprehensive program. Since many
devices with needlestick prevention
features are new, this section
primarily addresses their use,
including desirable characteristics,
examples, and data supporting their
effectiveness. However, other
prevention strategy factors that
must be addressed include
modification of hazardous work
practices, administrative changes to
address needle hazards in the
environment (e.g., prompt removal of
filled sharps disposal boxes),
safety education and awareness,
feedback on safety improvements, and
action taken on continuing problems.
The critical role of appropriate
training has been emphasized by
several recent reports of increased
patient bloodstream infections
associated with improper care of
needleless IV systems, primarily in
the home healthcare setting (NIOSH.
1999). These data emphasize the need
for patient safety surveillance and
thorough training as well as
occupational injury surveillance
when implementing the use of a new
medical device.
Case Study of a Successful
Comprehensive Prevention Program
(NIOSH. 1999)
The value of a comprehensive
approach is illustrated by its
success in a recent report. Between
1993 and 1996, the phlebotomy
service at a major institution
decreased the needlestick injury
rate among its 200 full-time
phlebotomists from 1.5 to 0.2 per
10,000 venipunctures performed. In
comparison, a national survey from
1990 to 1992 found a median
needlestick injury rate of about
0.94 per 10,000 venipunctures. A
retrospective review of the events
contributing to the success of the
phlebotomy service included changes
in worker education and work
practices, the implementation of
devices with safety features, and
encouragement of injury reporting.
These interventions as well as the
implementation of CDC published
guidelines and the OSHA bloodborne
pathogens standard were associated
with the observed steady decline in
the injury rate. The authors noted
that an important factor
contributing to this success was a
thorough understanding of the
injuries that occurred among their
staff.
Desirable Characteristics of Devices
with Safety Features
Improved engineering controls are
often among the most effective
approaches to reducing occupational
hazards and therefore are an
important element of a needlestick
prevention program. Such controls
include eliminating the unnecessary
use of needles and implementing
devices with safety features. A
number of sources have identified
the desirable characteristics of
safety devices]. These
characteristics include the
following (NIOSH. 1999):
|
The device is needleless. |
|
|
|
|
The safety feature is an
integral part of the device. |
|
|
|
|
The device preferably works
passively (i.e., it requires
no activation by the user).
If user activation is
necessary, the safety
feature can be engaged with
a single-handed technique
and allows the worker's
hands to remain behind the
exposed sharp. |
|
|
|
|
The user can easily tell
whether the safety feature
is activated. |
|
|
|
|
The safety feature cannot be
deactivated and remains
protective through disposal. |
|
|
|
|
The device performs
reliably. |
|
|
|
|
The device is easy to use
and practical. |
|
|
|
|
The device is safe and
effective for patient care. |
Although each of these
characteristics is desirable, some
are not feasible, applicable or
available for certain healthcare
situations. For example, needles
will always be necessary where
alternatives for skin penetration
are not available. Also, a safety
feature that requires activation by
the user might be preferable to one
that is passive in some cases. Each
device must be considered on its own
merit and ultimately on its ability
to reduce workplace injuries. The
desirable characteristics listed
here should thus serve only as a
guideline for device design and
selection.
Examples of Safety Device Designs
Figure 3 shows examples of syringes
with safety features. These and
other examples of safety device
designs are listed as follows
(NIOSH. 1999):
|
Needleless connectors for IV
delivery systems (e.g.,
blunt cannula for use with
prepierced ports and valved
connectors that accept
tapered or luer ends of IV
tubing) |
|
|
|
|
Protected needle IV
connectors (e.g., the IV
connector needle is
permanently recessed in a
rigid plastic housing that
fits over IV ports) |
|
|
|
|
Needles that retract into a
syringe or vacuum tube
holder |
|
|
|
|
Hinged or sliding shields
attached to phlebotomy
needles, winged-steel
needles, and blood gas
needles |
|
|
|
|
Protective encasements to
receive an IV stylet as it
is withdrawn from the
catheter |
|
|
|
|
Sliding needle shields
attached to disposable
syringes and vacuum tube
holders |
|
|
|
|
Self-blunting phlebotomy and
winged-steel needles (a
blunt cannula seated inside
the phlebotomy needle is
advanced beyond the needle
tip before the needle is
withdrawn from the vein—see
Figure 3) |
|
|
|
|
Retractable
finger/heel-stick lancets |
Evidence of Effectiveness
Accumulating evidence indicates that
devices with safety features reduce
needlestick injuries (NIOSH. 1999):
|
Needleless or
protected-needle IV systems
decreased needlestick
injuries related to IV
connectors by 62% to 88%. |
|
|
|
|
Phlebotomy injuries were
reduced by 76% with a
self-blunting needle, 66%
with a hinged needle shield,
and 23% with a
sliding-shield, winged-steel
(butterfly-type) needle. |
|
|
|
|
Phlebotomy injuries were
reduced by 82% with a needle
shield, but a recapping
device had minimal impact. |
|
|
|
|
Safer IV catheters that
encase the needle after use
reduced needlestick injuries
related to IV insertion by
83% in three hospitals. |
Other studies also document
substantial reductions in
needlestick injuries with the proper
use of needleless systems or newer
safety needle devices used in a
comprehensive program to prevent
needlestick injuries (NIOSH. 1999).
Although the focus in this section
is on needle devices with safety
features, sharps disposal containers
are also important engineering
controls to consider in a
comprehensive needlestick injury
prevention program. NIOSH recently
reviewed the proper location, use,
and benefits of sharps disposal
containers.
As illustrated by the examples
listed here, many devices with
safety features decrease the
frequency of needlestick injuries,
but for many reasons they do not
completely eliminate the risk. In
some cases, the safety feature
cannot be activated until after the
needle is removed from the patient.
Or the needle may be inadvertently
dislodged during a procedure,
thereby exposing the unprotected
sharp. Some healthcare workers fail
to activate the safety feature, or
the safety feature may fail. With
some devices, users can bypass
safety features. For example, even
with some needleless IV delivery
systems, a needle can be used to
connect parts of the system.
Understanding the factors that
influence the safety of a device and
promoting practices that will
maximize prevention effectiveness
are therefore important components
in prevention planning.
Selecting and Evaluating Needle
Devices with Safety Features
An increasing number and variety of
needle devices with safety features
are now available, but many of these
devices have had only limited use in
the workplace. Thus healthcare
organizations and workers may find
it difficult to select appropriate
devices. Although these devices are
designed to enhance the safety of
healthcare workers, they should be
evaluated to ensure that
|
the safety feature works
effectively and reliably, |
|
|
|
|
the device is acceptable to
the healthcare worker, and |
|
|
|
|
the device does not
adversely affect patient
care. |
As employers implement the use of
needle devices with safety features,
they can use several guidelines to
select and evaluate these products.
These guidelines are derived partly
from publications and other
resources offering plans, evaluation
forms, and related information in
this new area (NIOSH. 1999). While
healthcare settings are implementing
the use of needle devices with
safety features, they should seek
help from the appropriate
professional organizations, trade
groups, and manufacturers in
obtaining information about devices
and procedures suitable for specific
settings (e.g. dental offices).
The major elements of a process for
selecting and evaluating needle
devices with safety features are
listed here briefly (NIOSH. 1999):
|
1. |
Form a multidisciplinary
team that includes workers
to (1) develop, implement,
and evaluate a plan to
reduce needlestick injuries
in the institution and (2)
evaluate needle devices with
safety features. |
|
|
|
|
2. |
Identify priorities based on
assessments of how
needlestick injuries are
occurring, patterns of
device use in the
institution, and local and
national data on injury and
disease transmission trends.
Give the highest priority to
needle devices with safety
features that will have the
greatest impact on
preventing occupational
infection (e.g., hollow-bore
needles used in veins and
arteries). |
|
|
|
|
3. |
When selecting a safer
device, identify its
intended scope of use in the
healthcare facility and any
special technique or design
factors that will influence
its safety, efficiency, and
user acceptability. Seek
published, Internet, or
other sources of data on the
safety and overall
performance of the device. |
|
|
|
|
4. |
Conduct a product
evaluation, making sure that
the participants represent
the scope of eventual
product users. The following
steps will contribute to a
successful product
evaluation: |
|
|
|
|
5. |
Monitor the use of a new
device after it is
implemented to determine the
need for additional
training, solicit informal
feedback on healthcare
worker experience with the
device (e.g., using a
suggestion box), and
identify possible adverse
effects of the device on
patient care. |
Ongoing review of current devices
and options will be necessary. As
with any evolving technology, the
process will be dynamic, and with
experience, improved devices with
safety features will emerge.
Recommendations for Employers
To protect healthcare workers from
needlestick injuries, employers must
provide a safe working environment
that includes safer needle devices
and effective safety programs. Many
types of needle devices are
associated with needlestick
injuries, and these injuries can
occur in many ways. Thus a
combination of prevention strategies
must be considered. Employers should
take the following steps to
implement a program for reducing
needlestick injuries and to involve
workers in this effort (NIOSH.
1999).
|
1. |
Employers of healthcare
workers should implement the
use of improved engineering
controls to reduce
needlestick injuries: |
|
|
|
|
|
Eliminate the use of needle devices
where safe and effective
alternatives are available. The most
obvious example of unnecessary
needle use is the use of exposed
needles to access or connect parts
of an IV delivery system. For nearly
a decade, needleless IV delivery
systems and protected needles have
been available to remove or isolate
this hazard. Examine information
about your own institution to
identify other unnecessary needle
use. |
|
|
|
|
Implement the use of needle devices
with safety features and evaluate
their use to determine which are
most effective and acceptable. Many
devices are now available with
safety features that isolate an
exposed needle after use. An
evaluation approach and references
are provided in this document. |
|
2. |
Needlestick injury reduction
can best be accomplished
when the use of improved
engineering controls is
incorporated into a
comprehensive program
involving workers: |
|
|
|
|
|
Analyze needlestick and other
sharps-related injuries in your
workplace to identify hazards and
injury trends. Data from injury
reporting should be compiled and
assessed to identify (1) where, how,
with what devices, and when injuries
are occurring and (2) the groups of
healthcare workers being injured. |
|
|
|
|
Set priorities and prevention
strategies by examining local and
national information about risk
factors for needlestick injuries and
successful intervention efforts.
Procedures and devices that have
contributed to disease transmission
(e.g., devices used to access a vein
or artery) should receive the
highest priority for intervention.
Look to local and national resources
for information about the types of
devices and work practices that have
been successful in reducing
injuries. |
|
|
|
|
Ensure that healthcare workers are
properly trained in the safe use and
disposal of needles. Healthcare
workers and students in the health
professions should be trained to use
needle devices properly and to
maximize their personal protection
throughout the handling of these
devices. As safer devices are
introduced, worker training is
essential to ensure proper use. |
|
|
|
|
Modify work practices that pose a
needlestick injury hazard to make
them safer. Hazards that can be
eliminated by modifying work
practices include injuries due to
recapping, failing to dispose of a
needle device properly, passing or
transferring such a device, and
transferring blood or body fluids
from a device into a specimen
container. Also, specimen collection
can be coordinated to reduce the
number of times needles are used on
a patient, thereby reducing both
worker risk and patient discomfort.
In some cases, the use of devices
with safety features will reduce or
eliminate these risks. In all cases,
involving healthcare workers will
help identify and resolve safety
issues. Employers should thus review
current procedures for reporting and
addressing hazards related to
needles and other sharps. |
|
|
|
|
Promote safety awareness in the work
environment. Many needlestick
injuries result from unexpected
circumstances such as sudden
movement by a patient or collision
with a coworker or needle device.
Healthcare workers should be trained
to be constantly alert to the injury
potential when an exposed needle or
other sharp device is being used. A
number of job-related factors
influence the adoption of safety
behaviors by healthcare workers.
These workers often place patient
needs before their personal safety.
They are less likely to perform a
safety measure they perceive to
interfere with patient care or to
require added steps. Therefore,
employers must address both the
hazards that contribute to
needlestick injuries and the
institutional barriers and attitudes
that affect safe work practices. |
|
|
|
|
Establish procedures for and
encourage the reporting and timely
followup of all needlestick and
other sharps-related injuries.
Reporting of needlestick injuries is
essential to (1) ensure that all
healthcare workers receive
appropriate post-exposure medical
management and (2) provide a record
for assessing needlestick hazards in
the work environment. |
|
|
|
|
Evaluate the effectiveness of
prevention efforts and provide
feedback on performance. Employers
need to ensure that healthcare
workers are adopting the recommended
prevention strategies and that the
changes they make have the desired
effect. Thus, they should provide a
forum to assess worker perceptions,
evaluate compliance, and identify
problems. |
Recommendations for Workers
To protect them and their coworkers,
healthcare workers should be aware
of the hazards posed by needlestick
injuries and should use safety
devices and improved work practices
as follows (NIOSH. 1999):
|
1. |
Avoid the use of needles
where safe and effective
alternatives are available. |
|
|
|
|
2. |
Help your employer select
and evaluate devices with
safety features. |
|
|
|
|
3. |
Use devices with safety
features provided by your
employer. |
|
|
|
|
4. |
Avoid recapping needles. |
|
|
|
|
5. |
Plan safe handling and
disposal before beginning
any procedure using needles. |
|
|
|
|
6. |
Dispose of used needle
devices promptly in
appropriate sharps disposal
containers. |
|
|
|
|
7. |
Report all needlestick and
other sharps-related
injuries promptly to ensure
that you receive appropriate
followup care. |
|
|
|
|
8. |
Tell your employer about
hazards from needles that
you observe in your work
environment. |
|
|
|
|
9. |
Participate in bloodborne
pathogen training and follow
recommended infection
prevention practices,
including hepatitis B
vaccination. |
For additional information about
needlestick injuries, call
1-800-35-NIOSH (1-800-356-4674); or
visit the NIOSH Web site at
www.cdc.gov/niosh.
The following Web sites provide
additional information about
needlestick injuries and safer
needle devices:
Anonymous, (2003). Distraction,
anger, rushing associated with
sharps injuries. OR Manager 19(8) p
32. Retrieved October 29, 2003 from
this URL
Boebbeling, B. (2003). Lessons
regarding percutaneous injuries
among healthcare providers.
Infection Control and Hospital
Epidemiology. 24(2) p 82-86.
Retrieved October 29, 2003 from
this URL
DesRoches, P. & Moore, P. (2003).
HIV post-exposure prophylaxis (PEP)
- Effect on management of bloodborne
pathogen exposures in the healthcare
environment. AAOHN Journal. 51(9) p
370. Retrieved October 29, 2003 from
this URL
NIOSH. (1999). Alert: Preventing
needlestick injuries in healthcare
settings. DSSH NIOSH publication
2000-108. Retrieved October 29,
2003, from
this URL
Perry, J., Jagger, J. & Parker, G.
(2003). Statistically, your risk of
HCV Infection has dropped. Nursing.
33(6).
this URL
Perry, J., Jagger, J. & Parker, G.
(2003). Nurses and needlesticks,
then and now. Nursing. 33(4) p 22.
Retrieved October 29, 2003, from
this URL |